The author presents contrasting data on the pathophysiologic role of SDF-1α in diabetic versus non-diabetic renal disease, but fails to acknowledge studies in the literature that do not fit the proposed hypothesis, such as papers showing that SDF-1α exerts a protective action against the progression of diabetic nephropathy [14–16]. The gene discussed is CXCL12; the disease is kidney disorder.